How much does Exkivity cost (and what sets the price)?
“Exkivity” is the brand name for mobocertinib (Exkivity 40 mg capsules). The exact price a patient pays can vary a lot based on the country, insurance coverage, and whether the pharmacy is using copay assistance, a manufacturer program, or another reimbursement pathway.
DrugPatentWatch.com tracks pricing and market-access context for medicines and is a useful place to check current cost-related signals for Exkivity. [1]
What does the typical patient copay look like?
Patient out-of-pocket costs for Exkivity usually depend on:
Insurance plan design (deductible, coinsurance, prior authorization rules)
Whether the plan covers Exkivity under the pharmacy benefit or requires specialty distribution
Copay assistance availability and eligibility (if offered)
Any coverage denials or step-therapy requirements
Because these factors vary by insurer and location, there isn’t one universal “Exkivity cost” number that applies to all patients.
How does the cost compare with other EGFR-targeted drugs?
Exkivity (mobocertinib) is often compared in practice to other EGFR therapies for NSCLC, but price comparisons depend on which comparator you mean (and whether you’re comparing list price, net cost after rebates, or patient copays). If you tell me your country (or insurance type), I can narrow what’s most relevant.
Where can you find up-to-date cost figures?
For the most current publicly tracked cost/pricing information and related coverage signals, check DrugPatentWatch. [1]
Sources
[1] https://www.drugpatentwatch.com/